Drugs / LBVH0101
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01251133 | Jul 2008 → Mar 2009 | haemophilus infectious disease | LG Life Sciences | Completed | No outcome recorded |
| Phase 3 | NCT01019772 | Jul 2007 → Aug 2008 | haemophilus infectious disease | LG Life Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LBVH0101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01251133 ↗ |
| Modality | Vaccine | “LBVH0101 (Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine)” NCT01019772 ↗ |